{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:48:05Z","timestamp":1772772485165,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.4158\/ep.1.1.39","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:14:18Z","timestamp":1365203658000},"page":"39-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Growth Hormone, Skeletal Growth Factors and Osteoporosis"],"prefix":"10.1016","volume":"1","author":[{"given":"Ernesto","family":"Canalis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.1.1.39_bb0005","first-page":"155","article-title":"Skeletal growth factors","volume":"3","author":"Canalis","year":"1993","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.4158\/EP.1.1.39_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(05)83484-5","article-title":"Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency","volume":"122","author":"Saggese","year":"1993","journal-title":"J Pediatr"},{"key":"10.4158\/EP.1.1.39_bb0015","first-page":"118","article-title":"Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset","volume":"74","author":"Kaufman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.39_bb0020","first-page":"1344","article-title":"Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency","volume":"76","author":"O\u2019Halloran","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.39_bb0025","first-page":"1671","article-title":"Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses","volume":"77","author":"Amato","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.39_bb0030","first-page":"1452","article-title":"Biochemical assessment of bone formation and resorption in acromegaly","volume":"76","author":"Ezzat","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.39_bb0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF00298716","article-title":"Serum levels of bone GLA protein (Osteocalcin, BGP) and carboxyterminal propeptide-of type I procollagen (PICP) in acromegaly: Effects of long-term octreotide treatment","volume":"52","author":"Terzolo","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"10.4158\/EP.1.1.39_bb0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.7326\/0003-4819-111-7-567","article-title":"Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism","volume":"111","author":"Diamond","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.1.1.39_bb0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jbmr.5650080410","article-title":"Bone mineral density and parameters of bone metabolism in patients with acromegaly","volume":"8","author":"Kotzmann","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP.1.1.39_bb0050","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0889-8529(18)30455-9","article-title":"Insulin-like growth factors and aging","volume":"16","author":"Hammerman","year":"1987","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP.1.1.39_bb0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/jcem-70-2-519","article-title":"Effects of short term administration of recombinant human growth hormone to elderly people","volume":"70","author":"Marcus","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.39_bb0060","first-page":"1263","article-title":"Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration","volume":"74","author":"Mann","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.39_bb0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/endo.134.1.7506203","article-title":"Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells","volume":"134","author":"Okazaki","year":"1994","journal-title":"Endocrinology"},{"key":"10.4158\/EP.1.1.39_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2796.1992.tb00550.x","article-title":"Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis","volume":"2","author":"Ljunghall","year":"1992","journal-title":"J Int Med"},{"key":"10.4158\/EP.1.1.39_bb0075","doi-asserted-by":"crossref","first-page":"12190","DOI":"10.1073\/pnas.89.24.12190","article-title":"Ovariectomy selectively reduces the concentration of transforming growth factor \u00df in rat bone: implications for estrogen deficiency-associated bone loss","volume":"89","author":"Finkelman","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.4158\/EP.1.1.39_bb0080","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1210\/endo-126-3-1569","article-title":"Cortisol inhibits the synthesis of insulin-like growth factor I in skeletal cells","volume":"126","author":"McCarthy","year":"1990","journal-title":"Endocrinology"},{"key":"10.4158\/EP.1.1.39_bb0085","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1210\/endo.134.3.8119182","article-title":"Platelet-derived growth factor enhances bone cell replication but not differentiated function of osteoblasts","volume":"134","author":"Hock","year":"1994","journal-title":"Endocrinology"},{"key":"10.4158\/EP.1.1.39_bb0090","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jcem-70-3-718","article-title":"Somatomedin-C., physical fitness, and bone density","volume":"70","author":"Kelly","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.39_bb0095","first-page":"89","article-title":"Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth","volume":"259","author":"DeVol","year":"1990","journal-title":"Am J Physiol"},{"key":"10.4158\/EP.1.1.39_bb0100","first-page":"1","article-title":"Clinical Review 35 Growth factors and their potential clinical value","volume":"75","author":"Canalis","year":"1992","journal-title":"J Clin Endocrino Metab"},{"key":"10.4158\/EP.1.1.39_bb0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jbmr.5650070410","article-title":"Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis","volume":"7","author":"Ibbotson","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP.1.1.39_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/8756-3282(91)90050-S","article-title":"In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats","volume":"12","author":"Spencer","year":"1991","journal-title":"Bone"},{"key":"10.4158\/EP.1.1.39_bb0115","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1210\/endo.131.5.1425437","article-title":"Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats","volume":"131","author":"Tobias","year":"1992","journal-title":"Endocrinology"},{"key":"10.4158\/EP.1.1.39_bb0120","first-page":"1384","article-title":"Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women","volume":"77","author":"Ebeling","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.39_bb0125","first-page":"1183","article-title":"Role of insulin-like growth factor-1 in reversing catabolism","volume":"75","author":"Clemmons","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.39_bb0130","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1172\/JCI114072","article-title":"Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat","volume":"83","author":"Jacob","year":"1989","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.1.1.39_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI116212","article-title":"Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously","volume":"91","author":"Kupfer","year":"1993","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.1.1.39_bb0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI113885","article-title":"Insulin-like growth factor I mediates selected anabolic effects of parathyroid hormone in bone cultures","volume":"83","author":"Canalis","year":"1989","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.1.1.39_bb0145","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1210\/endo-127-4-1804","article-title":"Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone","volume":"127","author":"Hock","year":"1990","journal-title":"Endocrinology"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/A8DY2LK5YR83BV8F.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:16:12Z","timestamp":1761516972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20404136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["S1530891X20404136"],"URL":"https:\/\/doi.org\/10.4158\/ep.1.1.39","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[1995,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth Hormone, Skeletal Growth Factors and Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.1.1.39","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1995 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}